by Becker’s Payer | Mar 20, 2026 | Industry News, Medicare Advantage
For insurers that remain committed to their Medicare Advantage businesses, special needs plans have been a major growth driver. KFF estimated that almost half of MA enrollment growth from 2024 to 2025 stemmed from these tailored plans. In 2025, SNPs covered 21% of MA...
by KFF | Mar 13, 2026 | Industry News, Medicare, Medicare Advantage
Despite concerns raised by the industry, the Medicare Advantage market remains robust in terms of enrollment, plan choice, and extra benefits. Enrollment in Medicare Advantage surpassed 35 million people in February of 2026, as more than half of eligible beneficiaries...
by Becker's Payer | Mar 11, 2026 | CMS, Industry News, Medicare Advantage
Elevance said it was “surprised and disappointed” by a recent CMS sanction threat, which would suspend enrollment in Medicare Advantage prescription drug plans, CFO Mark Kaye said March 10 at the Barclays 28th Annual Global Healthcare Conference in Miami. The...
by KFF | Feb 23, 2026 | Industry News, Medicare, Medicare Advantage
The Centers for Medicare & Medicaid Services (CMS) released the latest Medicare Advantage enrollment data on February 13, 2026. These data provide the first look into Medicare Advantage enrollment for 2026 following a statement published by CMS last fall...
by Agent & Advisor | Feb 18, 2026 | Health, Industry News, Medicare, Medicare Advantage
Legislative change in Medicare may feel slow, but the proposals now on the table could reshape how licensed agents sell and support coverage as early as 2026. Lawmakers, regulators, and advocacy groups are signaling three major priorities: new restrictions on Medicare...
by Stat | Feb 5, 2026 | Industry News, Medicare Advantage
For 2026, 2.6 million seniors saw their MA prescription drug plans discontinued, double last year’s total. This erosion is not an accident of the market — it is the direct, predictable consequence of flawed policy, and it’s putting the stability of a vital program in...
